Skip to content

US · JUNS

Jupiter Neurosciences, Inc.

Sector
Healthcare · Biotechnology
Headquarters
Jupiter, FL 33477

Price · as of 2026-09-03

$3.26

Market cap 2.8M

Price history

Weekly OHLC price history for JUNS, USD per share
WeekOpenHighLowCloseVolume
Dec 2, 2024 – Dec 6, 2024$300.00$695.25$289.50$584.250
Dec 9, 2024 – Dec 13, 2024$597.75$1,425.00$518.25$915.750
Dec 16, 2024 – Dec 20, 2024$937.50$1,463.25$562.50$729.750
Dec 23, 2024 – Dec 27, 2024$807.75$960.93$787.50$826.500
Dec 30, 2024 – Jan 3, 2025$810.00$857.38$637.50$637.500
Jan 6, 2025 – Jan 10, 2025$660.00$711.75$637.50$641.250
Jan 13, 2025 – Jan 17, 2025$697.50$701.25$308.25$330.000
Jan 20, 2025 – Jan 24, 2025$333.75$420.00$87.00$105.750
Jan 27, 2025 – Jan 31, 2025$96.00$103.50$75.75$77.250
Feb 3, 2025 – Feb 7, 2025$76.50$85.50$62.25$65.000
Feb 10, 2025 – Feb 14, 2025$65.25$72.00$58.52$62.300
Feb 17, 2025 – Feb 21, 2025$62.31$65.45$58.88$62.760
Feb 24, 2025 – Feb 28, 2025$63.00$63.00$47.25$48.830
Mar 3, 2025 – Mar 7, 2025$47.48$51.00$41.25$50.250
Mar 10, 2025 – Mar 14, 2025$50.25$50.25$42.01$45.890
Mar 17, 2025 – Mar 21, 2025$46.50$60.00$43.66$56.630
Mar 24, 2025 – Mar 28, 2025$57.35$58.55$48.23$52.500
Mar 31, 2025 – Apr 4, 2025$48.75$50.63$41.25$44.030
Apr 7, 2025 – Apr 11, 2025$42.71$44.03$38.25$39.850
Apr 14, 2025 – Apr 17, 2025$38.25$61.80$38.25$46.500
Apr 21, 2025 – Apr 25, 2025$45.75$52.40$44.17$50.250
Apr 28, 2025 – May 2, 2025$51.53$52.43$45.18$48.000
May 5, 2025 – May 9, 2025$47.25$48.75$42.32$46.520
May 12, 2025 – May 16, 2025$48.00$51.15$42.75$43.880
May 19, 2025 – May 23, 2025$43.49$47.18$40.96$46.500
May 26, 2025 – May 30, 2025$43.77$65.78$43.77$58.130
Jun 2, 2025 – Jun 6, 2025$59.94$63.75$52.97$58.530
Jun 9, 2025 – Jun 13, 2025$59.67$171.75$59.67$84.750
Jun 16, 2025 – Jun 20, 2025$76.50$97.50$67.50$83.250
Jun 23, 2025 – Jun 27, 2025$87.75$94.50$75.00$78.750
Jun 30, 2025 – Jul 3, 2025$78.00$141.75$71.45$123.750
Jul 7, 2025 – Jul 11, 2025$120.00$205.50$104.25$171.750
Jul 14, 2025 – Jul 18, 2025$171.00$249.75$107.25$121.500
Jul 21, 2025 – Jul 25, 2025$122.25$138.75$120.75$121.500
Jul 28, 2025 – Aug 1, 2025$121.50$125.25$97.50$102.000
Aug 4, 2025 – Aug 8, 2025$105.00$115.50$85.50$90.750
Aug 11, 2025 – Aug 15, 2025$93.75$114.00$78.75$96.750
Aug 18, 2025 – Aug 22, 2025$94.50$124.50$90.00$114.000
Aug 25, 2025 – Aug 29, 2025$114.75$119.25$102.00$110.250
Sep 1, 2025 – Sep 5, 2025$111.00$115.50$90.00$92.250
Sep 8, 2025 – Sep 12, 2025$93.75$123.75$91.50$114.000
Sep 15, 2025 – Sep 19, 2025$111.75$121.50$105.00$107.250
Sep 22, 2025 – Sep 26, 2025$107.25$125.25$97.50$119.250
Sep 29, 2025 – Oct 3, 2025$123.75$138.00$114.00$122.250
Oct 6, 2025 – Oct 10, 2025$125.25$127.50$112.50$114.750
Oct 13, 2025 – Oct 17, 2025$114.75$128.25$108.00$119.250
Oct 20, 2025 – Oct 24, 2025$120.00$126.00$108.00$114.750
Oct 27, 2025 – Oct 31, 2025$123.75$135.75$102.00$107.250
Nov 3, 2025 – Nov 7, 2025$103.50$105.00$90.00$99.750
Nov 10, 2025 – Nov 14, 2025$99.75$103.50$95.25$100.500
Nov 17, 2025 – Nov 21, 2025$102.00$102.75$88.50$88.500
Nov 24, 2025 – Nov 28, 2025$92.25$97.50$86.25$92.250
Dec 1, 2025 – Dec 5, 2025$92.25$93.00$84.75$85.500
Dec 8, 2025 – Dec 12, 2025$87.00$96.75$82.50$84.000
Dec 15, 2025 – Dec 19, 2025$84.00$90.00$80.25$82.500
Dec 22, 2025 – Dec 26, 2025$75.75$90.00$75.00$85.500
Dec 29, 2025 – Jan 2, 2026$89.25$90.00$68.60$75.750
Jan 5, 2026 – Jan 9, 2026$75.75$81.75$73.51$79.500
Jan 12, 2026 – Jan 16, 2026$80.25$81.75$58.97$64.400
Jan 19, 2026 – Jan 23, 2026$63.00$73.50$61.57$66.750
Jan 26, 2026 – Jan 30, 2026$66.00$66.75$36.00$39.590
Feb 2, 2026 – Feb 6, 2026$39.77$47.25$37.88$44.960
Feb 9, 2026 – Feb 13, 2026$43.53$47.25$40.50$43.340
Feb 16, 2026 – Feb 20, 2026$42.76$44.98$38.27$38.990
Feb 23, 2026 – Feb 27, 2026$37.50$46.50$37.50$39.750
Mar 2, 2026 – Mar 6, 2026$37.50$39.74$27.98$29.030
Mar 9, 2026 – Mar 13, 2026$28.97$33.72$25.82$31.710
Mar 16, 2026 – Mar 20, 2026$33.00$33.01$24.75$31.130
Mar 23, 2026 – Mar 27, 2026$30.20$31.56$23.55$26.250
Mar 30, 2026 – Apr 2, 2026$26.45$29.54$22.96$27.650
Apr 6, 2026 – Apr 10, 2026$27.65$30.36$25.35$29.910
Apr 13, 2026 – Apr 17, 2026$29.85$37.50$25.96$32.790
Apr 20, 2026 – Apr 24, 2026$32.63$36.00$28.50$29.260
Apr 27, 2026 – May 1, 2026$29.93$31.42$25.52$29.250
May 4, 2026 – May 8, 2026$30.00$31.37$24.90$24.960
May 11, 2026 – May 15, 2026$25.50$29.27$24.76$25.350
May 18, 2026 – May 22, 2026$26.25$39.74$12.91$17.840
May 25, 2026 – May 29, 2026$17.75$21.75$16.49$19.200
Jun 1, 2026 – Jun 5, 2026$19.28$21.36$18.03$18.160
Jun 8, 2026 – Jun 12, 2026$18.00$18.37$16.06$17.940
Jun 15, 2026 – Jun 18, 2026$18.00$19.05$16.76$17.850
Jun 22, 2026 – Jun 26, 2026$18.00$22.37$16.66$21.000
Jun 29, 2026 – Jul 2, 2026$15.55$17.02$14.66$16.730
Jul 6, 2026 – Jul 10, 2026$15.98$17.24$13.19$14.240
Jul 13, 2026 – Jul 17, 2026$14.29$14.29$11.91$12.940
Jul 20, 2026 – Jul 24, 2026$13.13$17.91$8.25$9.070
Jul 27, 2026 – Jul 31, 2026$9.53$9.53$6.25$6.750
Aug 3, 2026 – Aug 7, 2026$6.74$8.25$4.76$5.100
Aug 10, 2026 – Aug 14, 2026$5.31$6.10$4.56$5.240
Aug 17, 2026 – Aug 21, 2026$5.10$11.20$4.74$6.200
Aug 24, 2026 – Aug 28, 2026$5.65$6.00$4.10$4.180
Aug 31, 2026 – Sep 3, 2026$3.00$3.65$2.88$3.260

Valuation

MetricValueUpside
IC Value$0.17-95%
P/E-0.02
P/B-0.11
P/S8.96
EV/EBITDA-0.20
PEG-0.01
P/TBV-0.11

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for JUNS, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024$0.67
2025$0.42

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Jupiter Neurosciences, Inc.

        Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.

        CEO
        Christer Rosen
        Employees
        5
        Beta
        1.96

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for JUNS: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        JUNSJupiter Neurosciences, In…$5.102.8M-0.02-0.118.96-0.20-0.01-0.1180.59%-40873.19%-39662.77%-738.83%-5596.28%-146.94%-2.90-134.940.650.51-0.18194.81%38.42%-2773.25%-0.73-3400.80%0.00%0.00%0.00%-0.19-0.3279.15-14.54
        ABVCABVC BioPharma, Inc.$1.0114.64M$9,273.20+918,039%-3.532.66-4.342.660.00%0.00%0.00%-135.79%-82.48%-58.58%0.31-17.200.410.24-0.38-7.14%-100.00%65.07%-10.11%-0.48-34.44%0.00%0.00%0.00%-4.51-10.80-4.16
        ALGSAligos Therapeutics, Inc.$4.7429.33M$8.68+83%-3.091.4034.23-0.101.4057.46%-4024.93%-1106.72%-196.92%182.19%-30.50%0.103.903.670.57-88.30%-44.59%2.56%-110.84%-3.89171.74%0.00%0.00%0.00%-0.03-0.031.02-11.29
        GNTAGenenta Science S.p.A.$1.3325.46M-2.300.690.950.690.00%0.00%0.00%-38.03%-1107.96%-27.96%0.35-16.5114.1613.90-0.35-32.65%10.10%-45.83%-3.24-1200.97%0.00%0.00%0.00%0.870.81-1.46
        GRCEGrace Therapeutics, Inc.$2.1434.83M-4.870.59-1.902.600.00%0.00%0.00%-11.94%-19.90%-11.24%0.008.107.921.53-58.41%-40.49%-23.36%-4.13-19.41%0.00%0.00%0.00%-1.90-2.373.19
        SKYESkye Bioscience, Inc.$0.5619.74M-0.471.31-0.01-0.501.310.00%0.00%0.00%-126.85%2216.67%-110.66%0.013.303.140.1093.15%60.46%-164.53%-5.251641.40%0.00%0.00%0.00%-0.01-0.02-13.32
        XFORX4 Pharmaceuticals, Inc.$4.15391.43M$87.98+2,020%-1.970.844.440.280.9882.18%-247.44%-225.55%-75.99%-1985.44%-36.25%0.41-9.7910.169.842.03-66.55%1273.21%-35.89%-56.78%-3.32-2025.09%0.00%0.00%103.90%0.230.22-0.56-1.86

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.17 ÷ $3.26) − 1 = -94.79% (IC, example).